Algorithms for More Accurate Biopsies
Need to Improve Data Preparation and IT Integration
We have two problems: Three out of ten patients without clear symptoms have acute pathology. And, conversely, nearly half of the patients classified as priority cases by clinicians turn out not to be urgent cases after all.Dr. Bram Stieltjes
Sophisticated Support for Thoracic Examinations
When radiologists create a report, there is a variability of about ten to 20 percent depending on the examiner. In an algorithm-based diagnosis, this variability is completely eliminated and the results are very consistent.Dr. Bram Stieltjes
Algorithms for Integrated Decision Support
In five to ten years, there will be hardly any diagnostic processes that are not supported by AI.Dr. Bram Stieltjes
Driver for Digitalization
AI-Rad Companion is 510(k) pending, and not yet commercially available in the United States and other countries.
AI-Pathway Companion is under development and not commercially available. Due to regulatory reasons its future availability cannot be ensured.
AI-Pathway Companion Prostate Cancer and AI-Pathway Companion Prostate Cancer Analytics VA10A are currently under development and planned to be commercially available in 2019. Due to regulatory reasons its future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.